Top Markets
Coin of the day
Akili, Inc. Akili, Inc.

Akili, Inc.

AKLI
Rank in Stocks #27311
Akili, Inc. is a digital medicine enterprise focused on developing innovative... Akili, Inc. is a digital medicine enterprise focused on developing innovative digital therapies for individuals experiencing cognitive impairments. Its flagship product, EndeavorRx, stands out as a unique video game-based treatment that necessitates a physician's prescription and is specifically engineered to directly target and improve cognitive functioning. This company operates from its headquarters in Boston, Massachusetts.
Share Price
$0.432
Last synced: 2024-07-02
Market Cap
$33.63M
Change (1 day)
-0.25%
Change (1 year)
0.00%
Country
US
Trade Akili, Inc. (AKLI)

Category

Revenue for Akili, Inc. (AKLI)
Revenue in Aug 2026 TTM: 0
According to Akili, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Akili, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors